NCT07533123 2026-04-16A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of CareJiangsu Alphamab Biopharmaceuticals Co., LtdPhase 3 Recruiting364 enrolled